Well lout, all I can say is that if my guess is correct and you were associated with previous management, no wonder the board and leading shareholders called for a review of activities.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025